Contact

All Stories

  1. IMAT-HCC model: Liver Stiffness–Enhanced Integrated Risk Stratification for HCC Recurrence After Resection

    Article • JHEP Reports, April 2026, Elsevier

    Dr. Federico Ravaioli

  2. HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients

    Article • Journal of Hepatocellular Carcinoma, January 2026, Taylor & Francis

    Dr. Federico Ravaioli

  3. Reply: Beyond semantics—Acknowledging diagnostic differences between NAFLD and MASLD

    Article • Hepatology, December 2025, Wolters Kluwer Health

    Dr. Federico Ravaioli

  4. Impact of first and further decompensation in patients with compensated ACLD due to MASLD

    Article • Journal of Hepatology, December 2025, Elsevier

    Dr. Federico Ravaioli

  5. Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab

    Article • Scientific Reports, November 2025, Springer Science + Business Media

    Dr. Federico Ravaioli

  6. Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

    Article • Journal of Hepatology, November 2025, Elsevier

    Dr. Federico Ravaioli

  7. Concomitant Autoimmune Liver Disease and Hepatic Actinomycosis: A Diagnostic Challenge—Brief Report and Review of the Literature

    Article • International Journal of Molecular Sciences, September 2025, MDPI AG

    Dr. Federico Ravaioli

  8. Pre-operative evaluation of spontaneous portosystemic shunts as a predictor of post-hepatectomy liver failure in patients undergoing liver resection for hepatocellular carcinoma

    Article • European Journal of Surgical Oncology, August 2025, Elsevier

    Dr. Federico Ravaioli

  9. Biopsy-free endpoints in MASH trials: A comparative look at MASHResInd and FAST

    Article • Hepatology, June 2025, Wolters Kluwer Health

    Dr. Federico Ravaioli

  10. Dietary Strategies to Modulate Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

    Article • Nutrients, June 2025, MDPI AG

    Dr. Federico Ravaioli

  11. Etiology of hepatocellular carcinoma may influence the pattern of progression under atezolizumab-bevacizumab.

    Article • Liver Cancer, May 2025, Karger Publishers

    Dr. Federico Ravaioli

  12. 32nd European Congress on Obesity (ECO 2025)

    Article • Obesity Facts, May 2025, Karger Publishers

    Dr. Federico Ravaioli

  13. LBP-034-YI Genetic characterization of adult-onset cryptogenic cholestasis: a prospective multicentre study of 233 patients

    Article • Journal of Hepatology, May 2025, Elsevier

    Dr. Federico Ravaioli

  14. THU-402-YI Real-world practice using liver stiffness measurement through two-dimensional shear wave elastography (SuperSonic Imagine) as a predictive tool for hepatocellular carcinoma risk in noncirrhotic MASLD patients

    Article • Journal of Hepatology, May 2025, Elsevier

    Dr. Federico Ravaioli

  15. Tu1604: EXTERNAL VALIDATION OF A PAN-ELASTOGRAPHIC MACHINE LEARNING MODEL FOR NON-INVASIVE DIAGNOSIS OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

    Article • Gastroenterology, May 2025, Elsevier

    Dr. Federico Ravaioli

  16. Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentr...

    Article • British Journal of Pharmacology, April 2025, Springer Science + Business Media

    Dr. Federico Ravaioli

  17. Balancing act: LDL-cholesterol control through plant-based vegan and Mediterranean diets

    Article • Mediterranean Journal of Nutrition and Metabolism, March 2025, SAGE Publications

    Dr. Federico Ravaioli

  18. Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

    Article • Frontiers in Oncology, March 2025, Frontiers

    Dr. Federico Ravaioli

  19. What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?

    Article • Expert Review of Gastroenterology & Hepatology, March 2025, Taylor & Francis

    Dr. Federico Ravaioli

  20. Generative Artificial Intelligence in Nutrition: A Revolution in Accessibility and Personalization

    Article • Journal of Nutrition, March 2025, Elsevier

    Dr. Federico Ravaioli

  21. Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation

    Article • Critical Reviews in Oncology/Hematology, March 2025, Elsevier

    Dr. Federico Ravaioli

  22. A Combined Model of Spleen Stiffness and Baveno VII Criteria for Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease: An International Multicenter Study

    Article • Portal Hypertension & Cirrhosis, March 2025, Wiley

    Dr. Federico Ravaioli

  23. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?

    Article • Digestive and Liver Disease, February 2025, Elsevier

    Dr. Federico Ravaioli

  24. Liver stiffness measurement by SuperSonic Imagine two-dimensional shear wave elastography to predict hepatocellular carcinoma in non-cirrhotic metabolic dysfunction-associated steatotic liver disease

    Article • Digestive and Liver Disease, February 2025, Elsevier

    Dr. Federico Ravaioli

  25. Small bites, big impact: The importance of evening snacks in patients with advanced chronic liver disease

    Article • World Journal of Hepatology, January 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Federico Ravaioli

  26. Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

    Article • Clinical and Molecular Hepatology, January 2025, The Korean Association for the Study of the Liver (KAMJE)

    Dr. Federico Ravaioli

  27. Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multilevel random effects model meta-analysis

    Article • Hepatology, December 2024, Wolters Kluwer Health

    Dr. Federico Ravaioli

  28. Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis

    Article • Annals of Surgical Oncology, December 2024, Springer Science + Business Media

    Dr. Federico Ravaioli

  29. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study

    Article • The Lancet Gastroenterology & Hepatology, December 2024, Elsevier

    Dr. Federico Ravaioli

  30. Malnutrition independently predicts mortality at 18 months in patients hospitalised for severe acute respiratory syndrome corona virus 2 (SARS-coV-2)

    Article • Clinical Nutrition ESPEN, October 2024, Elsevier

    Dr. Federico Ravaioli

  31. New insights on portal hypertension’s screening in people with cystic fibrosis

    Article • HepatoBiliary Surgery and Nutrition, October 2024, AME Publishing Company

    Dr. Federico Ravaioli

  32. Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: Prevalence, noninvasive diagnosis, and burden on surgical outcomes

    Article • Liver Transplantation, September 2024, Wolters Kluwer Health

    Dr. Federico Ravaioli

  33. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives

    Article • International Journal of Molecular Sciences, August 2024, MDPI AG

    Dr. Federico Ravaioli

  34. Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis

    Article • JHEP Reports, August 2024, Elsevier

    Dr. Federico Ravaioli

  35. Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder

    Article • Hepatology, July 2024, Wolters Kluwer Health

    Dr. Federico Ravaioli

  36. A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease

    Article • Hepatology International, June 2024, Springer Science + Business Media

    Dr Benjamin Mullish, Dr. Federico Ravaioli

  37. WED-232-YI Diagnostic accuracy of two-dimensional shear wave elastography (2D-SWE) for non-invasive assessment of liver fibrosis in biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD). Systematic-review and multi-level random...

    Article • Journal of Hepatology, June 2024, Elsevier

    Dr. Federico Ravaioli

  38. Evaluation of ChatGPT as a Counselling Tool for Italian-Speaking MASLD Patients: Assessment of Accuracy, Completeness and Comprehensibility

    Article • Journal of Personalized Medicine, May 2024, MDPI AG

    Dr. Federico Ravaioli

  39. Metformin and the Liver: Unlocking the Full Therapeutic Potential

    Article • Metabolites, March 2024, MDPI AG

    Dr. Federico Ravaioli

  40. Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease

    Article • Hepatology, February 2024, Wolters Kluwer Health

    Dr. Federico Ravaioli

  41. Reply: Diagnostic accuracy of AGILE3+ score for advanced fibrosis in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis

    Article • Hepatology, December 2023, Wolters Kluwer Health

    Dr. Federico Ravaioli

  42. Diagnostic accuracy of AGILE 3+ score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis

    Article • Hepatology, November 2023, Wolters Kluwer Health

    Dr. Federico Ravaioli

  43. The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study

    Article • Liver International, September 2023, Wiley

    Dr. Federico Ravaioli

  44. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis

    Article • The Lancet Gastroenterology & Hepatology, September 2023, Elsevier

    Dr. Federico Ravaioli

  45. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

    Article • JHEP Reports, September 2023, Elsevier

    Dr. Federico Ravaioli

  46. Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis

    Article • Nutrients, August 2023, MDPI AG

    Dr. Federico Ravaioli

  47. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

    Article • JHEP Reports, August 2023, Elsevier

    Dr. Federico Ravaioli

  48. From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients

    Article • Nutrients, June 2023, MDPI AG

    Dr. Federico Ravaioli

  49. Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study

    Article • Liver International, June 2023, Wiley

    Dr. Federico Ravaioli

  50. A pragmatic strategy for the screening and treatment of portal hypertension in patients needing systemic treatment for advanced hepatocellular carcinoma

    Article • Digestive and Liver Disease, June 2023, Elsevier

    Dr. Federico Ravaioli

  51. Individual and population screening of varices needing treatment by a simple, safe and accurate test

    Article • Clinics and Research in Hepatology and Gastroenterology, May 2023, Elsevier

    Dr. Federico Ravaioli

  52. The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis

    Article • Digestive and Liver Disease, May 2023, Elsevier

    Dr. Federico Ravaioli

  53. Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease

    Article • International Journal of Molecular Sciences, April 2023, MDPI AG

    Dr. Federico Ravaioli

  54. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

    Article • Journal of Hepatocellular Carcinoma, March 2023, Taylor & Francis

    Dr. Federico Ravaioli

  55. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced nonalcoholic fatty liver disease

    Article • Digestive and Liver Disease, March 2023, Elsevier

    Dr. Federico Ravaioli

  56. Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives

    Article • Nutrients, February 2023, MDPI AG

    Dr. Federico Ravaioli

  57. Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis

    Article • Gut, January 2023, BMJ

    Dr. Federico Ravaioli

  58. Letter to the Editor Regarding the Article “Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Diagnosing Hepatocellular Carcinoma: Diagnostic Performance and Interobserver Agreement” by Zhou and Collaborators

    Article • Ultraschall in der Medizin - European Journal of Ultrasound, November 2022, Thieme Publishing Group

    Dr. Federico Ravaioli

  59. Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies

    Article • Digestive and Liver Disease, November 2022, Elsevier

    Dr. Federico Ravaioli

  60. Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation

    Article • Frontiers in Oncology, September 2022, Frontiers

    Dr. Federico Ravaioli

  61. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

    Article • Digestive and Liver Disease, September 2022, Elsevier

    Dr. Federico Ravaioli

  62. Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Dr. Federico Ravaioli

  63. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment

    Article • Clinics and Research in Hepatology and Gastroenterology, August 2022, Elsevier

    Dr. Federico Ravaioli

  64. A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

    Article • The American Journal of Gastroenterology, July 2022, Wolters Kluwer Health

    Dr. Federico Ravaioli

  65. Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm

    Article • Journal of Hepatology, July 2022, Elsevier

    Dr. Federico Ravaioli

  66. Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy

    Article • Journal of Hepatology, July 2022, Elsevier

    Dr. Federico Ravaioli

  67. Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH)

    Article • Journal of Hepatology, July 2022, Elsevier

    Dr. Federico Ravaioli

  68. Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

    Article • Digestive and Liver Disease, July 2022, Elsevier

    Dr. Federico Ravaioli

  69. Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis

    Article • Cancers, April 2022, MDPI AG

    Dr. Federico Ravaioli

  70. Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis

    Article • International Journal of Obesity, March 2022, Springer Science + Business Media

    Dr. Federico Ravaioli

  71. Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm

    Article • Digestive and Liver Disease, March 2022, Elsevier

    Dr. Federico Ravaioli

  72. Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy

    Article • Digestive and Liver Disease, March 2022, Elsevier

    Dr. Federico Ravaioli

  73. Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients

    Article • European Journal of Radiology, February 2022, Elsevier

    Dr. Federico Ravaioli

  74. Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients

    Article • Digestive and Liver Disease, January 2022, Elsevier

    Dr. Federico Ravaioli

  75. Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia

    Article • Cancer Medicine, December 2021, Wiley

    Dr. Federico Ravaioli

  76. Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up

    Article • Clinical Nutrition ESPEN, December 2021, Elsevier

    Dr. Federico Ravaioli

  77. Clinical Presentation of Celiac Disease and Diagnosis Accuracy in a Single-Center European Pediatric Cohort over 10 Years

    Article • Nutrients, November 2021, MDPI AG

    Dr. Federico Ravaioli

  78. Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

    Article • European Journal of Cancer, November 2021, Elsevier

    Dr. Federico Ravaioli

  79. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice

    Article • World Journal of Hepatology, August 2021, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Federico Ravaioli

  80. Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges

    Article • Nutrients, August 2021, MDPI AG

    Dr. Federico Ravaioli

  81. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.

    Article • Digestive and Liver Disease, August 2021, Elsevier

    Dr. Federico Ravaioli

  82. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

    Article • Liver Cancer International, July 2021, Wiley

    Dr. Federico Ravaioli

  83. Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness

    Article • JHEP Reports, June 2021, Elsevier

    Dr. Federico Ravaioli

  84. A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study

    Article • Cancers, May 2021, MDPI AG

    Dr. Federico Ravaioli

  85. The role of liver and spleen elastography in advanced chronic liver disease

    Article • Minerva Gastroenterology, May 2021, Edizioni Minerva Medica

    Dr. Federico Ravaioli

  86. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment

    Article • Clinical Gastroenterology and Hepatology, April 2021, Elsevier

    Dr. Federico Ravaioli

  87. Pattern of macrovascular invasion in hepatocellular carcinoma

    Article • European Journal of Clinical Investigation, March 2021, Wiley

    Dr. Federico Ravaioli

  88. Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease

    Article • Clinical Nutrition, March 2021, Elsevier

    Dr. Federico Ravaioli, Prof. Loris Pironi

  89. Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis

    Article • Liver International, February 2021, Wiley

    Dr. Federico Ravaioli, Prof. Loris Pironi

  90. Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases

    Article • HPB, January 2021, Elsevier

    Dr. Federico Ravaioli

  91. Liver and Spleen Stiffness in Vascular Liver Disease

    Article • January 2021, Springer Science + Business Media

    Dr. Federico Ravaioli

  92. The changing scenario of hepatocellular carcinoma in Italy: an update

    Article • Liver International, December 2020, Wiley

    Dr. Federico Ravaioli

  93. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    Article • Science Translational Medicine, December 2020, American Association for the Advancement of Science

    Dr. Federico Ravaioli

  94. Malnutrition in hospitalized patients with SARS-CoV-2 infection

    Article • Clinical Nutrition ESPEN, December 2020, Elsevier

    Dr. Federico Ravaioli

  95. Transition of patients with chronic intestinal failure from paediatric to adult center

    Article • Clinical Nutrition ESPEN, December 2020, Elsevier

    Dr. Federico Ravaioli

  96. Clinical impact of sarcopenia assessment in patients with liver cirrhosis

    Article • Expert Review of Gastroenterology & Hepatology, November 2020, Taylor & Francis

    Dr. Federico Ravaioli

  97. Monofocal hepatocellular carcinoma: How much does size matter?

    Article • Liver International, November 2020, Wiley

    Dr. Federico Ravaioli

  98. Reply to: “Response to A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma”

    Article • Journal of Hepatology, November 2020, Elsevier

    Dr. Federico Ravaioli

  99. Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?

    Article • Pancreas, October 2020, Wolters Kluwer Health

    Dr. Federico Ravaioli

  100. UEG Week 2020 Poster Presentations

    Article • United European Gastroenterology Journal, October 2020, SAGE Publications

    Sergey Morozov, Dr. Federico Ravaioli, Dr Francisco José Eiroa-Orosa

  101. A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma

    Article • Journal of Hepatology, October 2020, Elsevier

    Dr. Federico Ravaioli

  102. Imaging in Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

    Article • Biology of Blood and Marrow Transplantation, October 2020, Elsevier

    Dr. Federico Ravaioli

  103. Reply to: “Liver stiffness: A novel predictor of postoperative complications in patients with hepatocellular carcinoma”

    Article • Journal of Hepatology, October 2020, Elsevier

    Dr. Federico Ravaioli

  104. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes

    Article • Diabetes & Metabolism, September 2020, Elsevier

    Dr. Federico Ravaioli

  105. Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study

    Article • Journal of Gastroenterology and Hepatology, August 2020, Wiley

    Dr. Federico Ravaioli

  106. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments

    Article • Journal of Gastroenterology, August 2020, Springer Science + Business Media

    Dr. Federico Ravaioli

  107. Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk

    Article • HepatoBiliary Surgery and Nutrition, August 2020, AME Publishing Company

    Dr. Federico Ravaioli

  108. Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation After Direct-Acting Antivirals in HCV Cirrhotic Patients

    Article • Ultraschall in der Medizin - European Journal of Ultrasound, July 2020, Thieme Publishing Group

    Dr. Federico Ravaioli

  109. Non-invasive tests for the prediction of primary hepatocellular carcinoma

    Article • World Journal of Gastroenterology, June 2020, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Federico Ravaioli

  110. Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly

    Article • Hepatoma Research, June 2020, OAE Publishing

    Dr. Federico Ravaioli

  111. Predictive factors for hepatocellular carcinoma recurrence after curative treatments

    Article • Hepatoma Research, June 2020, OAE Publishing

    Dr. Federico Ravaioli

  112. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients

    Article • Hepatology International, June 2020, Springer Science + Business Media

    Dr. Federico Ravaioli

  113. Pancreatic ultrasound elastography is not useful to predict the risk of pancreatic fistulas after pancreatic resection

    Article • Updates in Surgery, April 2020, Springer Science + Business Media

    Dr. Federico Ravaioli

  114. Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Frontiers in Immunology, April 2020, Frontiers

    Dr. Federico Ravaioli

  115. Comparison of prognostic models in predicting survival of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: a multicenter cohort study

    Article • Digestive and Liver Disease, February 2020, Elsevier

    Dr. Federico Ravaioli

  116. Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient

    Article • Digestive and Liver Disease, February 2020, Elsevier

    Dr. Federico Ravaioli

  117. Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C

    Article • Journal of Gastrointestinal and Liver Diseases, December 2019, Romanian Society of Gastroenterology and Heptatology

    Dr. Federico Ravaioli

  118. A novel spleen‐dedicated stiffness measurement by FibroScan® improves the screening of high‐risk oesophageal varices

    Article • Liver International, September 2019, Wiley

    Dr. Federico Ravaioli

  119. Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance

    Article • Digestive Diseases and Sciences, July 2019, Springer Science + Business Media

    Dr. Federico Ravaioli

  120. IDDF2019-ABS-0108 Hepatic decompensation risk is reduced, but not eliminated after direct-acting antivirals: the role of spleen stiffness measurement

    Article • June 2019, BMJ

    Dr. Federico Ravaioli

  121. Longitudinal evaluation of liver stiffness in three pediatric patients with veno‐occlusive disease

    Article • Pediatric Transplantation, May 2019, Wiley

    Dr. Federico Ravaioli

  122. Editorial: collagen proportionate area as a prognostic indicator in NAFLD

    Article • Alimentary Pharmacology & Therapeutics, May 2019, Wiley

    Dr. Federico Ravaioli

  123. Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study

    Article • Biology of Blood and Marrow Transplantation, May 2019, Elsevier

    Dr. Federico Ravaioli

  124. Reply to correspondence concerning: “Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection”

    Article • Journal of Hepatology, April 2019, Elsevier

    Dr. Federico Ravaioli

  125. Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review

    Article • Expert Review of Gastroenterology & Hepatology, March 2019, Taylor & Francis

    Dr. Federico Ravaioli

  126. “Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?”

    Article • Digestive and Liver Disease, March 2019, Elsevier

    Dr. Federico Ravaioli

  127. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection

    Article • Journal of Hepatology, March 2019, Elsevier

    Dr. Federico Ravaioli

  128. Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients

    Article • Digestive and Liver Disease, February 2019, Elsevier

    Dr. Federico Ravaioli

  129. Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome

    Article • Canadian Journal of Gastroenterology and Hepatology, January 2019, Hindawi Publishing Corporation

    Dr. Federico Ravaioli

  130. Prediction of posthepatectomy liver failure: Role of SSM and LSPS

    Article • Journal of Surgical Oncology, December 2018, Wiley

    Dr. Federico Ravaioli

  131. Ruolo e significato clinico dei metodi non invasivi nella valutazione dell’ipertensione portale nel paziente affetto da epatopatia cronica

    Article • Recenti Progressi in Medicina, December 2018, Il Pensiero Scientifico Editore

    Dr. Federico Ravaioli

  132. Transient Elastography Anticipates the Diagnosis of VOD/SOS after Adult Allogeneic Stem Cell Transplant: Results from a Prospective Study

    Article • Blood, November 2018, American Society of Hematology

    Dr. Federico Ravaioli

  133. Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients

    Article • World Journal of Hepatology, October 2018, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr. Federico Ravaioli

  134. How to clarify the Baveno VI criteria for ruling out varices needing treatment by noninvasive tests

    Article • Liver International, September 2018, Wiley

    Dr. Federico Ravaioli

  135. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals

    Article • Digestive and Liver Disease, September 2018, Elsevier

    Dr. Federico Ravaioli

  136. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease

    Article • Journal of Hepatology, August 2018, Elsevier

    Dr. Federico Ravaioli

  137. Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update

    Article • Gastroenterology Research and Practice, June 2018, Hindawi Publishing Corporation

    Dr Andrea Lisotti, Dr. Federico Ravaioli

  138. Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals

    Article • Digestive and Liver Disease, June 2018, Elsevier

    Dr. Federico Ravaioli

  139. Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808]

    Article • Digestive and Liver Disease, June 2018, Elsevier

    Dr. Federico Ravaioli

  140. Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals

    Article • Gastroenterology, June 2018, Elsevier

    Dr. Federico Ravaioli

  141. Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection

    Article • Pancreatology, June 2018, Elsevier

    Dr. Federico Ravaioli

  142. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case-control study

    Article • Oncotarget, April 2018, Impact Journals, LLC

    Dr. Federico Ravaioli

  143. A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr. Federico Ravaioli

  144. Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients

    Article • Journal of Hepatology, April 2018, Elsevier

    Dr. Federico Ravaioli

  145. Correction to: Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness

    Article • Journal of Ultrasound, March 2018, Springer Science + Business Media

    Dr. Federico Ravaioli

  146. PC.01.2 A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND

    Article • Digestive and Liver Disease, March 2018, Elsevier

    Dr. Federico Ravaioli

  147. P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C

    Article • Digestive and Liver Disease, March 2018, Elsevier

    Dr. Federico Ravaioli

  148. A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond

    Article • Digestive and Liver Disease, February 2018, Elsevier

    Dr. Federico Ravaioli

  149. IL28 polymorphism and HCC after DAAs for chronic hepatitis C

    Article • Digestive and Liver Disease, February 2018, Elsevier

    Dr. Federico Ravaioli

  150. Liver stiffness predicts the development of portal hypertension related complications in advanced chronic liver disease

    Article • Digestive and Liver Disease, February 2018, Elsevier

    Dr. Federico Ravaioli

  151. Spleen Stiffness by Ultrasound Elastography

    Article • January 2018, Springer Science + Business Media

    Dr. Federico Ravaioli

  152. Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness

    Article • Journal of Ultrasound, August 2017, Springer Science + Business Media

    Dr. Federico Ravaioli

  153. Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study

    Article • Digestive and Liver Disease, July 2017, Elsevier

    Dr. Federico Ravaioli

  154. DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr. Federico Ravaioli

  155. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr. Federico Ravaioli

  156. Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr. Federico Ravaioli

  157. The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients

    Article • Digestive and Liver Disease, February 2017, Elsevier

    Dr. Federico Ravaioli

  158. DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr. Federico Ravaioli

  159. The role of spleen stiffness measurement as predictor of hepatocellular carcinoma recurrence after curative resection in cirrhotic patients

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr. Federico Ravaioli

  160. Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr. Federico Ravaioli

  161. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients

    Article • Journal of Hepatology, January 2017, Elsevier

    Dr. Federico Ravaioli

  162. Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT

    Article • British Journal of Pharmacology, December 2016, Springer Science + Business Media

    Dr. Federico Ravaioli

  163. Encefalopatia epatica

    Article • Recenti Progressi in Medicina, July 2016, Il Pensiero Scientifico Editore

    Dr. Federico Ravaioli

  164. Gut Microbiota and Celiac Disease

    Article • Digestive Diseases and Sciences, January 2016, Springer Science + Business Media

    Dr. Federico Ravaioli